Recall company profile

Noven Pharmaceuticals, Inc. Recalls

Overview of recall records associated with Noven Pharmaceuticals, Inc., including dates, categories and classifications where available.

46recall records
Nov 27, 2024latest record date
Jun 20, 2012earliest record date

Recall history in this database

Classification mix: Class II: 45, Class III: 1.

DrugDec 7, 2022

Daytrana recall — FDA D-0071-2023

Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugJul 6, 2022

Daytrana recall — FDA D-1169-2022

Defective Delivery System: Customer complaints received for ripping patches and tight release/adhesive transfer.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugJun 1, 2022

Daytrana recall — FDA D-0889-2022

Defective Delivery System: customer complaints exceeded respective action limits.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugJun 2, 2021

Daytrana recall — FDA D-0393-2021

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugJun 2, 2021

Daytrana recall — FDA D-0394-2021

Defective Delivery System: The number of customer complaints for ripping patches and tight release/adhesive transfer have exceeded the action limits.

Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugApr 28, 2021

Minivelle recall — FDA D-0336-2021

Defective Delivery System: Out of specification for release rate testing and shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could…

Class IIFDA: TerminatedNoven Pharmaceuticals Inc.
DrugOct 3, 2018

Minivelle recall — FDA D-1209-2018

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugOct 3, 2018

Minivelle recall — FDA D-1207-2018

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugOct 3, 2018

Minivelle recall — FDA D-1210-2018

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugOct 3, 2018

Minivelle recall — FDA D-1208-2018

Defective Delivery System: out of specification results for shear, an attribute related to the adhesive properties of the transdermal patches.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugMay 16, 2018

Minivelle recall — FDA D-0862-2018

Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience…

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugMay 16, 2018

Minivelle recall — FDA D-0863-2018

Defective Delivery System: no longer meets the specification for shear, an attribute related to the adhesive properties of the transdermal patches. As a result, patients could experience…

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugSep 27, 2017

Daytrana recall — FDA D-1171-2017

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugSep 27, 2017

Daytrana recall — FDA D-1170-2017

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.
DrugSep 27, 2017

Daytrana recall — FDA D-1172-2017

Defective Delivery System: Products no longer meet the release liner removal specification and/or z-statistic.

Class IIFDA: TerminatedNoven Pharmaceuticals, Inc.

Understanding this recall history

This page summarizes recall records in which the official source identifies Noven Pharmaceuticals, Inc. as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.

Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.